ANGIODYNAMICS INC — Director's Dealing 2023

Sep 21, 2023

SEC Form 4/A — Form 4/A

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2023-07-19

Reporting Person: Helsel Dave (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-19	Common Stock	M	9650	—	Acquired	37939	Direct
2023-07-19	Common Stock	F	3477	$8.92	Disposed	34462	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-19	Performance Right	$	M	15081	Disposed		Common Stock (15081)	Direct

Footnotes

F1: This acquisition of 9,650 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020.

F2: The exempt disposition of 3,477 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020.

F3: On July 14, 2020, the reporting person received a target grant of 15,081 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 9,650 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.